Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lithium, Bevacizumab, Temozolomide, and Radiation for High Grade Glioma
NCT01105702Phase 2Terminated
- Sponsor
- NYU Langone Health
- Start
- May 2010
- Primary completion
- Apr 2014
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of lithium carbonate in high-grade glioma (HGG), sponsored by NYU Langone Health. Started May 2010; status: terminated.
02
Drugs
lithium carbonate
03
Conditions
high-grade glioma (HGG)
Beyond the preview
Go deeper on NCT01105702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01105702.